Literature DB >> 1312607

Protective immune response against foot-and-mouth disease.

K C McCullough1, F De Simone, E Brocchi, L Capucci, J R Crowther, U Kihm.   

Abstract

The causative agents of foot-and-mouth disease (FMD) are small icosahedral viruses of the Aphthovirus group within the Picornaviridae family. There is no evidence that these viruses infect cells of the immune system or otherwise interfere detrimentally with their function; additionally, it has not been possible to relate cytotoxicity reactions against virus-infected cells to the efficacy of the immune response against FMD virus infection. In contrast, there is a close association between FMD virus antibody and the protective immune response (10, 14, 15, 20, 24, 25, 29-32). Induction of this antibody is dependent on the structure of the viral antigenic sites (7-9, 11, 18) and on the concomitant presence of Th-lymphocyte epitopes (4, 5, 7, 8), although a Th-lymphocyte-independent response has been reported (2). Recent work by Piatti et al. (26) showed that the immune response induced by FMD virus was only Th-lymphocyte dependent when low doses of antigen were used. This latter work was performed in mice, and it is not certain that a similar situation would be found in cattle. As for the major effector immune defense, this relies on the interaction between antibody-virus complexes and the phagocytic cells of the reticuloendothelial system (17, 19).

Entities:  

Mesh:

Year:  1992        PMID: 1312607      PMCID: PMC288969     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Analysis of immune responses in the sheep to synthetic peptides of foot-and-mouth disease virus using ovine polyclonal and monoclonal antibodies.

Authors:  J N Flynn; G D Harkiss; T Doel; R DiMarchi
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

2.  A liquid-phase ELISA and its use in the identification of epitopes on foot-and-mouth disease virus antigens.

Authors:  K C McCullough; J R Crowther; R N Butcher
Journal:  J Virol Methods       Date:  1985-08       Impact factor: 2.014

3.  Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.

Authors:  Q C Xie; D McCahon; J R Crowther; G J Belsham; K C McCullough
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

4.  [The effectiveness of foot-and-mouth disease vaccines in Switzerland. I. Screening tests and herd immunity].

Authors:  H K Müller; F Villinger; C Griot; M Ackermann; L Bruckner; U Kihm
Journal:  Schweiz Arch Tierheilkd       Date:  1989       Impact factor: 0.845

5.  Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants.

Authors:  M J Francis; G Z Hastings; A D Syred; B McGinn; F Brown; D J Rowlands
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

6.  The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI.

Authors:  R H Meloen; J Briaire; R J Woortmeyer; D van Zaane
Journal:  J Gen Virol       Date:  1983-05       Impact factor: 3.891

7.  Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.

Authors:  M J Francis; G Z Hastings; B E Clarke; A L Brown; C R Beddell; D J Rowlands; F Brown
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

8.  Opsonization-enhanced phagocytosis of foot-and-mouth disease virus.

Authors:  K C McCullough; D Parkinson; J R Crowther
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

9.  Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus.

Authors:  G Mulcahy; C Gale; P Robertson; S Iyisan; R D DiMarchi; T R Doel
Journal:  Vaccine       Date:  1990-06       Impact factor: 3.641

10.  Immune response to foot-and-mouth disease virus in a murine experimental model: effective thymus-independent primary and secondary reaction.

Authors:  M V Borca; F M Fernández; A M Sadir; M Braun; A A Schudel
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

View more
  60 in total

1.  Genetical and immunological analysis of recent Asian type A and O foot-and-mouth disease virus isolates.

Authors:  B Freiberg; M M Rahman; O Marquardt
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

Review 2.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 3.  Options for control of foot-and-mouth disease: knowledge, capability and policy.

Authors:  David J Paton; Keith J Sumption; Bryan Charleston
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-09-27       Impact factor: 6.237

4.  Structure of a neutralizing antibody bound monovalently to human rhinovirus 2.

Authors:  E A Hewat; T C Marlovits; D Blaas
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.

Authors:  J Chinsangaram; C Beard; P W Mason; M K Zellner; G Ward; M J Grubman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Failure of vaccination to prevent outbreaks of foot-and-mouth disease.

Authors:  M E Woolhouse; D T Haydon; A Pearson; R P Kitching
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

7.  A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.

Authors:  O Taboga; C Tami; E Carrillo; J I Núñez; A Rodríguez; J C Saíz; E Blanco; M L Valero; X Roig; J A Camarero; D Andreu; M G Mateu; E Giralt; E Domingo; F Sobrino; E L Palma
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle.

Authors:  Nicholas Juleff; Miriam Windsor; Eric A Lefevre; Simon Gubbins; Pip Hamblin; Elizabeth Reid; Kerry McLaughlin; Peter C L Beverley; Ivan W Morrison; Bryan Charleston
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

9.  New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.

Authors:  Teresa Rodríguez-Calvo; Samuel Ojosnegros; Marta Sanz-Ramos; Juan García-Arriaza; Cristina Escarmís; Esteban Domingo; Noemí Sevilla
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

10.  Antigenic analysis of type O foot-and-mouth disease virus in the persistently infected bovine.

Authors:  J S Salt; A R Samuel; R P Kitching
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.